Questions regarding the reduction of the incidence of stage 4 breast cancer in Europe-authors' reply.

Rafael Cardoso; Idris Ola; Hermann Brenner

doi:10.1016/j.lanepe.2026.101661

← 뒤로

Questions regarding the reduction of the incidence of stage 4 breast cancer in Europe-authors' reply.

사설/논평 1/5 보강

The Lancet regional health. Europe 2026 Vol.65() p. 101661 OA Breast Cancer Treatment Studies

OpenAlex 토픽 · Breast Cancer Treatment Studies Global Cancer Incidence and Screening Multiple and Secondary Primary Cancers

Cardoso R, Ola I, Brenner H

📖 무료 전문 🟢 PMC 전문 PMC13022566 🔓 OA PDF oa

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Rafael Cardoso, Idris Ola, Hermann Brenner (2026). Questions regarding the reduction of the incidence of stage 4 breast cancer in Europe-authors' reply.. The Lancet regional health. Europe, 65, 101661. https://doi.org/10.1016/j.lanepe.2026.101661

MLA Rafael Cardoso, et al.. "Questions regarding the reduction of the incidence of stage 4 breast cancer in Europe-authors' reply.." The Lancet regional health. Europe, vol. 65, 2026, pp. 101661.

PMID 41909763 ↗

DOI 10.1016/j.lanepe.2026.101661

같은 제1저자의 인용 많은 논문 (2)

The Vanishing Colorectal Tumor: Lessons from an Illustrative Case Report.
GE Portuguese journal of gastroenterology 2026
Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study.
The Lancet regional health. Europe 2026

📖 전문 본문 읽기 PMC JATS · ~3 KB · 영문

Contributors

Contributors
RC, IO, and HB contributed to the drafting of this response.

Declaration of interests

Declaration of interests
RC was employed by The Lancet Regional Health—Europe as a senior editor from 1st April 2024 to 30th September 2025. He had no involvement in the peer review for this Correspondence, or the original Article, where he is an author. IO and HB have no conflicts of interest to declare.

출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.